BioNTech Insider Sale: Poetting’s 50,000 Shares Won’t Sink Momentum – What Investors Need to Know
BioNTech insider sale by COO Sierk Poetting: 50,000 shares sold amid rising shares, strong oncology pipeline and resilient liquidity – not a bearish signal.
3 minutes to read